Literature DB >> 33264666

Transcriptomic profiling of phospholipase A2 and the role of arachidonic acid during Brucella abortus 544 infection in both in vitro and in vivo systems.

Son Hai Vu1, Alisha Wehdnesday Bernardo Reyes2, Tran Xuan Ngoc Huy2, Wongi Min2, Hu Jang Lee2, Hyun Jin Kim2, John Hwa Lee3, Suk Kim4.   

Abstract

To date, the antimicrobial activity of arachidonic acid (AA) with regard to pathogenesis of Brucella in macrophages is unknown. We found that AA is highly toxic to B. abortus in a time- and dose-dependent manner. Transcription profiling of different groups of phospholipases A2 (PLA2) was examined, ten PLA2 were detected including cPLA2-IV-A, cPLA2-IV-B, iPLA2-VI, sPLA2-I-B, sPLA2-II-C, sPLA2-II-D, sPLA2-II-E, sPLA2-V, sPLA2-X, sPLA2-XII-A. Phagocytic signaling investigation indicated that AA treatment attenuated p38α activity in infected culture macrophages possibly leading to inhibition of Brucella internalization. Post-treatment with the fatty acid did not influence bacterial intracellular multiplication or alter production of antimicrobial effectors like ROS and NO in RAW 264.7 cells. On the other hand, AA administration significantly reduced bacterial load and modestly inhibited pro-inflammatory cytokine secretion including TNF, IFN-γ and IL-6 in mice plasma. To our knowledge, we are the first to suggest that B. abortus invasion to RAW 264.7 macrophages is impaired by AA.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Arachidonic acid; Brucella; Internalization; MAPK; Macrophage; PLA(2)

Mesh:

Substances:

Year:  2020        PMID: 33264666     DOI: 10.1016/j.micpath.2020.104655

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  1 in total

1.  Clinical application of compound Glycyrrhizin tablets in the treatment of patients with Simplex Henoch-Schonlein Purpura and its effect on immune function.

Authors:  Chao Li; Zhi-Bin Wang
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.